Biovitrum
Encyclopedia
Swedish Orphan Biovitrum (Sobi) is a Swedish pharmaceutical company, based in Stockholm
, Sweden
, with a product portfolio consisting of some 60 orphan
and specialty pharmaceuticals.
and Upjohn
and Monsanto Company in 1999. Since its creation, the company has gone through multiple transitions from a research intensive and diversified company to the current entity, focused on niche pharmaceuticals and specialist medical care. Its plasma product division was sold in 2002 to Octapharma
. Biovitrum retained its recombinant factor VIII product, Refacto, which has been a major source of revenue during the company's early consolidation phase. In 2005, Biovitrum acquired the Swedish biotech company Arexis and the British company Cambridge Biotechnology Ltd, strengthening its portfolio in bio-pharmaceuticals and clinical projects. The company's in-house research effort has been reduced over the years and it is now more reliant on in-licensing for its project portfolio management.
In January 2010 Biovitrum acquired Swedish Orphan International Holding AB and in June 2010 the company was renamed Swedish Orphan Biovitrum AB (publ).
Stockholm
Stockholm is the capital and the largest city of Sweden and constitutes the most populated urban area in Scandinavia. Stockholm is the most populous city in Sweden, with a population of 851,155 in the municipality , 1.37 million in the urban area , and around 2.1 million in the metropolitan area...
, Sweden
Sweden
Sweden , officially the Kingdom of Sweden , is a Nordic country on the Scandinavian Peninsula in Northern Europe. Sweden borders with Norway and Finland and is connected to Denmark by a bridge-tunnel across the Öresund....
, with a product portfolio consisting of some 60 orphan
Orphan drug
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease...
and specialty pharmaceuticals.
History
Biovitrum was created in 2001 as a spinoff from Pharmacia Corp. in the wake of the merger between the parent company PharmaciaPharmacia
Pharmacia was a pharmaceutical and biotechnological company in Sweden.-History:Pharmacia was founded in 1911 in Stockholm, Sweden by pharmacist Gustav Felix Grönfeldt at the Elgen Pharmacy. The company is named after the Greek word φαρμακεία, transliterated pharmakeia, which means 'sorcery'...
and Upjohn
Upjohn
The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested...
and Monsanto Company in 1999. Since its creation, the company has gone through multiple transitions from a research intensive and diversified company to the current entity, focused on niche pharmaceuticals and specialist medical care. Its plasma product division was sold in 2002 to Octapharma
Octapharma
Octapharma AG is the largest privately owned plasma product manufacturer in the world. It is headquartered in Lachen, Switzerland.Octapharma’s core business is the development, production and sale of high quality human proteins derived from blood plasma or recombinant technologies...
. Biovitrum retained its recombinant factor VIII product, Refacto, which has been a major source of revenue during the company's early consolidation phase. In 2005, Biovitrum acquired the Swedish biotech company Arexis and the British company Cambridge Biotechnology Ltd, strengthening its portfolio in bio-pharmaceuticals and clinical projects. The company's in-house research effort has been reduced over the years and it is now more reliant on in-licensing for its project portfolio management.
In January 2010 Biovitrum acquired Swedish Orphan International Holding AB and in June 2010 the company was renamed Swedish Orphan Biovitrum AB (publ).